After reading this Essential CPE module and completing the assessment, pharmacists should be able to: • Describe the immune dysfunction that occurs in rheumatoid arthritis • Recognise the risk factors for developing rheumatoid arthritis and the markers for more severe disease • Recognise the signs and symptoms of early rheumatoid arthritis and the clinical manifestations of developed disease • Recognise the importance of early diagnosis and the impact of untreated disease for sufferers of rheumatoid arthritis • Briefly describe the different types of arthritis that affect children • Briefly describe the diagnosis, pathology and radiology and the criteria that are applied in the diagnosis of rheumatoid arthritis • Identify the treatment aims and goals in rheumatoid arthritis • Describe the therapies used to treat acute flares of rheumatoid arthritis • Describe the different pharmacotherapy options available in the management of mild, moderate and severe rheumatoid arthritis • Recognise the importance of combination DMARD therapy in the management of moderate and severe rheumatoid arthritis • Recognise the monitoring of the most often used medicines in the treatment of rheumatoid arthritis.
N/A
N/A
N/A
978-0-646-52101-5
N/A
N/A
44
N/A
Pharmaceutical Society of Australia
N/A
Australia
N/A
N/A
N/A
N/A
N/A